找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Imaging Tumor Response to Therapy; Massimo Aglietta,Daniele Regge Book 2012 Springer-Verlag Italia Srl 2012 Assessment of Response.Functio

[復(fù)制鏈接]
樓主: PLY
21#
發(fā)表于 2025-3-25 06:56:46 | 只看該作者
Gastrointestinal Stromal Tumorses from a highly prevalent tumor the “micro-GIST,” which is < 2 cm wide [1] and is estimated to occur in up to 22% of the general population, to a rare disease characterized by a tumor > 2 cm and with an annual incidence of about 15/1,000,000 [2]. While the clinical relevance of microGIST is still u
22#
發(fā)表于 2025-3-25 08:04:59 | 只看該作者
Renal Cancerl increase in the incidence of this disease is 2% [1, 2]. More than 50% of RCCs are diagnosed incidentally and are asymptomatic. The classic triad of flank pain, gross hematuria, and a palpable abdominal mass is seen in very few patients (6–10%). Paraneoplastic symptoms (e.g., hypertension, weight l
23#
發(fā)表于 2025-3-25 15:08:55 | 只看該作者
Liver Metastases in Colon Cancerosis in another 40–50% [1]. Although liver resection is currently the only therapy producing long-term cure, at diagnosis 80% of patients are not considered to be candidates for resection because of the size, location, and extent of their disease. Radiofrequency ablation has been proposed as an alte
24#
發(fā)表于 2025-3-25 18:15:58 | 只看該作者
Neoadjuvant Therapy in Breast Cancercally, NAT was initially used in women with locally advanced breast cancer. In this setting it represented the only chance for a patient with an otherwise inoperable cancer of the breast to obtain a tumor regression that made surgery feasible. These experiences in locally advanced tumors suggested t
25#
發(fā)表于 2025-3-25 23:24:32 | 只看該作者
Lung Cancer challenge. Both local relapses and distant metastases are frequent, with a 5-year survival of 3–17% for inoperable disease [2]. According to the data released by the IASLC Lung Cancer Staging Project in 2007, the 5-year survival rates for the new clinical stages were 50%, 47%, 36%, 26%, 19%, 7%, an
26#
發(fā)表于 2025-3-26 01:47:08 | 只看該作者
27#
發(fā)表于 2025-3-26 05:12:01 | 只看該作者
Hepatocellular Carcinomas incidence has invariably increased over the last several decades and it is expected to continue rising, although the etiological landscape, until now dominated by hepatotropic viruses, may change in favor of metabolic diseases that involve the liver [2]. HCC is, in fact, currently most often assoc
28#
發(fā)表于 2025-3-26 10:57:29 | 只看該作者
https://doi.org/10.1007/978-88-470-2613-1Assessment of Response; Functional Imaging; Oncology; Radiology
29#
發(fā)表于 2025-3-26 12:50:09 | 只看該作者
978-88-470-3922-3Springer-Verlag Italia Srl 2012
30#
發(fā)表于 2025-3-26 19:30:29 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-23 01:27
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
和林格尔县| 伊通| 南丹县| 保靖县| 珠海市| 泽州县| 子长县| 正阳县| 唐海县| 双江| 常宁市| 永丰县| 伊金霍洛旗| 龙门县| 永新县| 开江县| 宜丰县| 南投县| 永川市| 太保市| 来凤县| 阿坝| 嘉定区| 威远县| 于都县| 开阳县| 长治县| 株洲县| 遵义县| 玛多县| 大城县| 巧家县| 满城县| 松溪县| 平江县| 灌阳县| 连山| 渭源县| 广丰县| 中江县| 广德县|